Dr. Juan P Alderuccio, MD
Claim this profileUniversity of Miami
Studies Follicular Lymphoma
Studies Non-Hodgkin's Lymphoma
4 reported clinical trials
8 drugs studied
Area of expertise
1Follicular Lymphoma
MYC positive
BCL2 positive
BCL6 positive
2Non-Hodgkin's Lymphoma
MYC positive
BCL2 positive
BCL6 positive
Affiliated Hospitals
Clinical Trials Juan P Alderuccio, MD is currently running
Zanubrutinib Combination Therapy
for Central Nervous System Lymphoma
The purpose of this study is to is to determine the effects (good and bad) of Zanubrutinib in Combination with Pola-R-CHP and High-dose Methotrexate in patients with Secondary Central Nervous System (CNS) Lymphoma.
Recruiting1 award Phase 13 criteria
Loncastuximab Tesirine + Rituximab
for Follicular Lymphoma
The purpose of this research is to see if Loncastuximab Tesirine in combination with Rituximab will result in higher complete response rate when given to treat follicular lymphoma.
Recruiting1 award Phase 2
More about Juan P Alderuccio, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Juan P Alderuccio, MD has experience with
- Rituximab
- Zanubrutinib
- Loncastuximab Tesirine
- PIT565
- Cyclophosphamide
- Oral Azacitidine
Breakdown of trials Juan P Alderuccio, MD has run
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Central Nervous System Lymphoma
Acute Lymphoblastic Leukemia
Mediastinal Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Juan P Alderuccio, MD specialize in?
Juan P Alderuccio, MD focuses on Follicular Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Follicular Lymphoma has involved MYC positive patients, or patients who are BCL2 positive.
Is Juan P Alderuccio, MD currently recruiting for clinical trials?
Yes, Juan P Alderuccio, MD is currently recruiting for 3 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Juan P Alderuccio, MD has studied deeply?
Yes, Juan P Alderuccio, MD has studied treatments such as Rituximab, Zanubrutinib, Loncastuximab tesirine.
What is the best way to schedule an appointment with Juan P Alderuccio, MD?
Apply for one of the trials that Juan P Alderuccio, MD is conducting.
What is the office address of Juan P Alderuccio, MD?
The office of Juan P Alderuccio, MD is located at: University of Miami, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.